SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-044146
Filing Date
2012-08-09
Accepted
2012-08-09 17:13:53
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v318572_10q.htm 10-Q 308712
2 EXHIBIT 31.1 v318572_ex31-1.htm EX-31.1 9086
3 EXHIBIT 31.2 v318572_ex31-2.htm EX-31.2 9045
4 EXHIBIT 32.1 v318572_ex32-1.htm EX-32.1 4186
  Complete submission text file 0001144204-12-044146.txt   2932629

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nvlt-20120630.xml EX-101.INS 353154
6 XBRL TAXONOMY EXTENSION SCHEMA nvlt-20120630.xsd EX-101.SCH 34261
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvlt-20120630_cal.xml EX-101.CAL 33937
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvlt-20120630_def.xml EX-101.DEF 145513
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlt-20120630_lab.xml EX-101.LAB 285428
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlt-20120630_pre.xml EX-101.PRE 182431
Mailing Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458
Business Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458 617-244-1616
NOVELOS THERAPEUTICS, INC. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-119366 | Film No.: 121021499
SIC: 2834 Pharmaceutical Preparations